Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580970 · ClinicalTrials.gov registry record · Phase 2
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 73
- Enrollment target
NCT00580970 is a Phase 2 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 73 participants.
The verdict
NCT00580970, a Phase 2 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 73 participants
- Enrollment target
Study Summary
Lovastatin may protect against late effects of radiation therapy in patients with prostate cancer
Interventions
- DRUG lovastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2007-04 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580970
The ClinicalTrials.gov registry entry for NCT00580970 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lovastatin is the first listed.
NCT00580970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00580970 about?
NCT00580970 is a clinical study titled "Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury". Lovastatin may protect against late effects of radiation therapy in patients with prostate cancer
What is the current status of trial NCT00580970?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 73 participants. The study started on 2007-04. Estimated completion is 2015-08.
What interventions are being tested in trial NCT00580970?
The interventions under investigation include: lovastatin (DRUG).
Who is sponsoring clinical trial NCT00580970?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.